Balyasny Asset Management’s Biomea Fusion BMEA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-40,477
Closed -$409K 2751
2024
Q3
$409K Buy
40,477
+24,778
+158% +$161K ﹤0.01% 2344
2024
Q2
$70.6K Sell
15,699
-11,425
-42% -$116K ﹤0.01% 2424
2024
Q1
$406K Buy
27,124
+4,696
+21% +$77.3K ﹤0.01% 2136
2023
Q4
$326K Buy
+22,428
New +$273K ﹤0.01% 2122
2023
Q2
Sell
-7,695
Closed -$239K 2299
2023
Q1
$239K Sell
7,695
-2,726
-26% -$33.9K ﹤0.01% 2185
2022
Q4
$87.8K Buy
+10,421
New +$88.9K ﹤0.01% 2266

Other funds holding BMEA

Balyasny Asset Management's BMEA Position: Q4 2024 in Review

Balyasny Asset Management sold out of Biomea Fusion (BMEA) in Q4 2024, closing a stake of 40,477 shares — an estimated $409K sold.

Balyasny Asset Management first reported a position in BMEA in Q4 2022 and held it in 6 quarters. The position peaked at $409K in Q3 2024. 108 funds tracked by Wall St. Rank hold BMEA as of Q4 2024.

  • Balyasny Asset Management reported no remaining Biomea Fusion position as of Q4 2024 after selling out during the quarter.
  • Balyasny Asset Management sold 40,477 Biomea Fusion shares in Q4 2024, an estimated $409K.
  • Balyasny Asset Management first reported a position in Biomea Fusion in Q4 2022 and held it in 6 quarters.
  • Balyasny Asset Management's Biomea Fusion position peaked at $409K in Q3 2024.
  • 108 funds tracked by Wall St. Rank held Biomea Fusion as of Q4 2024.

Based on Balyasny Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.